Akero Therapeutics logo

Akero Therapeutics Employee Directory

Biotechnology ResearchCalifornia, United States51-200 Employees

Akero Therapeutics is a clinical-stage biotechnology company headquartered in South San Francisco, California, focused on developing treatments for serious metabolic diseases with high unmet medical need, including MASH. Its lead product candidate, EFX, is being evaluated in the SYMMETRY study, a 96-week Phase 2b trial in patients with compensated cirrhosis due to MASH (F4 fibrosis), and there are three ongoing Phase 3 trials in pre-cirrhotic MASH or compensated cirrhosis: SYNCHRONY Histology, SYNCHRONY Real-World, and SYNCHRONY Outcomes. The SYNCHRONY program builds on two Phase 2b trials, the HARMONY study in pre-cirrhotic MASH (F2-F3) and the SYMMETRY study in compensated cirrhosis due to MASH (F4). The company has 51 to 200 employees and is located at 601 Gateway Boulevard, Suite 350, South San Francisco, CA 94080. In October 2025, Novo Nordisk announced plans to acquire Akero Therapeutics for about $4.7 billion in cash. Financial data indicate revenue in the range of $25 million to $50 million and total funding of $367 million.

Find Akero Therapeutics employees' phone numbers or email addresses

Akero Therapeutics Global Highlights

Location
Employees

North America
75

Minus sign iconPlus sign icon
  • United States Of America
    75

Europe
7

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    6
  • Romania
    1

Asia
3

Minus sign iconPlus sign icon
  • India
    2
  • Turkey
    1

Oceania
1

Minus sign iconPlus sign icon
  • Australia
    1

Akero Therapeutics's Leadership

  • Stylized image of a person
    D. S.
    Chief Operating Officer
    Phone icon
  • Stylized image of a person
    T. R.
    Chief Scientific Officer
    Phone icon
  • Stylized image of a person
    A. C.
    President
    Phone icon
  • Stylized image of a person
    S. E.
    Founder
    Phone icon
  • Stylized image of a person
    L. L.
    Vice President, Head Of Regulatory Affairs
    Phone icon
  • Stylized image of a person
    J. Z.
    Director
    Phone icon
  • Stylized image of a person
    C. T.
    Director, Regulatory Affairs
    Phone icon
  • Stylized image of a person
    E. W.
    Director, Business Operations
    Phone icon

Akero Therapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Engineering
  • Operations
  • Program & Project Management
  • Research
  • Finance
  • Other
  • Biotechnology
  • Business
  • Quality Assurance
  • Legal
  • Accounting

Contact profiles from Akero Therapeutics

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    A. C.
    President
    Phone icon
    Jun 07, 2026
  • Stylized image of a person
    D. S.
    Chief Operating Officer
    Phone icon
    UNITED KINGDOMEast Sussex
    Oct 31, 2023
  • Stylized image of a person
    S. E.
    Founder
    Phone icon
    UNITED KINGDOMEast Sussex
    May 09, 2026
  • Stylized image of a person
    T. R.
    Chief Scientific Officer
    Phone icon
    Dec 09, 2025
  • Stylized image of a person
    L. L.
    Vice President, Head Of Regulatory Affairs
    Phone icon
    Jul 28, 2026
  • Stylized image of a person
    J. Z.
    Director
    Phone icon
    Jul 28, 2026
  • Stylized image of a person
    C. T.
    Director, Regulatory Affairs
    Phone icon
    Bay
    Jun 27, 2026
  • Stylized image of a person
    E. W.
    Director, Business Operations
    Phone icon
    Jul 28, 2026
  • Stylized image of a person
    V. F.
    Senior Director, Packaging & Human Factors
    Phone icon
    Sep 21, 2024
  • Stylized image of a person
    V. V. P.
    Senior Finance Manager
    Phone icon
    Bay
    May 06, 2026

Frequently Asked Questions

What is Akero Therapeutics known for?

Minus sign iconPlus sign icon
Akero Therapeutics was founded in 2017 operates in the Biotechnology Research industry; you can contact the main corporate office by phone at . Explore Akero Therapeutics's company overview page for more information.

What is Akero Therapeutics's most common email format?

Minus sign iconPlus sign icon
Akero Therapeutics employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Akero Therapeutics email formats with LeadIQ.

How many employees does Akero Therapeutics have currently?

Minus sign iconPlus sign icon
Akero Therapeutics has approximately 74 employees as of July 2026. These team members are located across 4 continents, including North AmericaEuropeAsia.

Who are Akero Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of July 2026, Akero Therapeutics's key employees include:

  • Chief Operating Officer: D. S.
  • Chief Scientific Officer: T. R.
  • President: A. C.
  • Founder: S. E.
  • Vice President, Head Of Regulatory Affairs: L. L.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.